Literature DB >> 25122145

Early-onset autosomal recessive cerebellar ataxia associated with retinal dystrophy: new human hotfoot phenotype caused by homozygous GRID2 deletion.

Kristof Van Schil1, Françoise Meire2, Marcus Karlstetter3, Miriam Bauwens1, Hannah Verdin1, Frauke Coppieters1, Eva Scheiffert3, Christian Van Nechel4, Thomas Langmann3, Nicolas Deconinck5, Elfride De Baere1.   

Abstract

PURPOSE: The aim of this study was to identify the genetic cause of early-onset autosomal recessive cerebellar ataxia associated with retinal dystrophy in a consanguineous family.
METHODS: An affected 6-month-old child underwent neurological and ophthalmological examinations. Genetic analyses included homozygosity mapping, copy number analysis, conventional polymerase chain reaction, Sanger sequencing, quantitative polymerase chain reaction, and whole-exome sequencing. Expression analysis of GRID2 was performed by quantitative polymerase chain reaction and immunohistochemistry.
RESULTS: A homozygous deletion of exon 2 of GRID2 (p.Gly30_Glu81del) was identified in the proband. GRID2 encodes an ionotropic glutamate receptor known to be selectively expressed in cerebellar Purkinje cells. Here, we demonstrated GRID2 expression in human adult retina and retinal pigment epithelium. In addition, Grid2 expression was demonstrated in different stages of murine retinal development. GRID2 immunostaining was shown in murine and human retina. Whole-exome sequencing in the proband did not provide arguments for other disease-causing mutations, supporting the idea that the phenotype observed represents a single clinical entity.
CONCLUSION: We identified GRID2 as an underlying disease gene of early-onset autosomal recessive cerebellar ataxia with retinal dystrophy, expanding the clinical spectrum of GRID2 deletion mutants. We demonstrated for the first time GRID2 expression and localization in human and murine retina, providing evidence for a novel functional role of GRID2 in the retina.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25122145     DOI: 10.1038/gim.2014.95

Source DB:  PubMed          Journal:  Genet Med        ISSN: 1098-3600            Impact factor:   8.822


  28 in total

1.  Orphan glutamate receptor delta1 subunit required for high-frequency hearing.

Authors:  Jiangang Gao; Stéphane F Maison; Xudong Wu; Keiko Hirose; Sherri M Jones; Ildar Bayazitov; Yong Tian; Guy Mittleman; Douglas B Matthews; Stanislav S Zakharenko; M Charles Liberman; Jian Zuo
Journal:  Mol Cell Biol       Date:  2007-04-16       Impact factor: 4.272

2.  De novo partial deletion in GRID2 presenting with complicated spastic paraplegia.

Authors:  André Maier; Eva Klopocki; Denise Horn; Andreas Tzschach; Teresa Holm; Robert Meyer; Thomas Meyer
Journal:  Muscle Nerve       Date:  2013-12-16       Impact factor: 3.217

3.  Selective expression of the glutamate receptor channel delta 2 subunit in cerebellar Purkinje cells.

Authors:  K Araki; H Meguro; E Kushiya; C Takayama; Y Inoue; M Mishina
Journal:  Biochem Biophys Res Commun       Date:  1993-12-30       Impact factor: 3.575

4.  Ho15J: a new hotfoot allele in a hot spot in the gene encoding the delta2 glutamate receptor.

Authors:  Junko Motohashi; Wataru Kakegawa; Michisuke Yuzaki
Journal:  Brain Res       Date:  2006-05-02       Impact factor: 3.252

5.  Acute cerebellar ataxia and consecutive cerebellitis produced by glutamate receptor delta2 autoantibody.

Authors:  Takashi Shiihara; Mitsuhiro Kato; Akihiro Konno; Yukitoshi Takahashi; Kiyoshi Hayasaka
Journal:  Brain Dev       Date:  2006-10-16       Impact factor: 1.961

6.  Deletions in GRID2 lead to a recessive syndrome of cerebellar ataxia and tonic upgaze in humans.

Authors:  L Benjamin Hills; Amira Masri; Kotaro Konno; Wataru Kakegawa; Anh-Thu N Lam; Elizabeth Lim-Melia; Nandini Chandy; R Sean Hill; Jennifer N Partlow; Muna Al-Saffar; Ramzi Nasir; Joan M Stoler; A James Barkovich; Masahiko Watanabe; Michisuke Yuzaki; Ganeshwaran H Mochida
Journal:  Neurology       Date:  2013-09-27       Impact factor: 9.910

7.  CRX ChIP-seq reveals the cis-regulatory architecture of mouse photoreceptors.

Authors:  Joseph C Corbo; Karen A Lawrence; Marcus Karlstetter; Connie A Myers; Musa Abdelaziz; William Dirkes; Karin Weigelt; Martin Seifert; Vladimir Benes; Lars G Fritsche; Bernhard H F Weber; Thomas Langmann
Journal:  Genome Res       Date:  2010-08-06       Impact factor: 9.043

8.  Hotfoot mouse mutations affect the delta 2 glutamate receptor gene and are allelic to lurcher.

Authors:  A Lalouette; J L Guénet; S Vriz
Journal:  Genomics       Date:  1998-05-15       Impact factor: 5.736

9.  A homozygous deletion in GRID2 causes a human phenotype with cerebellar ataxia and atrophy.

Authors:  G Eda Utine; Göknur Haliloğlu; Bilge Salanci; Arda Çetinkaya; P Özlem Kiper; Yasemin Alanay; Dilek Aktas; Koray Boduroğlu; Mehmet Alikaşifoğlu
Journal:  J Child Neurol       Date:  2013-04-22       Impact factor: 1.987

10.  A hot spot for hotfoot mutations in the gene encoding the delta2 glutamate receptor.

Authors:  Ying Wang; Shinji Matsuda; Valerie Drews; Takashi Torashima; Miriam H Meisler; Michisuke Yuzaki
Journal:  Eur J Neurosci       Date:  2003-04       Impact factor: 3.386

View more
  22 in total

Review 1.  Genetic landscape remodelling in spinocerebellar ataxias: the influence of next-generation sequencing.

Authors:  Marie Coutelier; Giovanni Stevanin; Alexis Brice
Journal:  J Neurol       Date:  2015-04-11       Impact factor: 4.849

2.  Pre-B Lymphocyte Protein 3 (VPREB3) Expression in the Adrenal Cortex: Precedent for non-Immunological Roles in Normal and Neoplastic Human Tissues.

Authors:  Saulo J A Felizola; Koshin Katsu; Kazue Ise; Yasuhiro Nakamura; Yoichi Arai; Fumitoshi Satoh; Hironobu Sasano
Journal:  Endocr Pathol       Date:  2015-05       Impact factor: 3.943

Review 3.  Fragility Extraordinaire: Unsolved Mysteries of Chromosome Fragile Sites.

Authors:  Wenyi Feng; Arijita Chakraborty
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

4.  GRID2 Mutation-Related Spinocerebellar Ataxia Type 18: A New Report and Literature Review.

Authors:  Prateek Kumar Panda; Indar Kumar Sharawat; Lesa Dawman
Journal:  J Pediatr Genet       Date:  2020-11-25

Review 5.  Structure, Function, and Pharmacology of Glutamate Receptor Ion Channels.

Authors:  Kasper B Hansen; Lonnie P Wollmuth; Derek Bowie; Hiro Furukawa; Frank S Menniti; Alexander I Sobolevsky; Geoffrey T Swanson; Sharon A Swanger; Ingo H Greger; Terunaga Nakagawa; Chris J McBain; Vasanthi Jayaraman; Chian-Ming Low; Mark L Dell'Acqua; Jeffrey S Diamond; Chad R Camp; Riley E Perszyk; Hongjie Yuan; Stephen F Traynelis
Journal:  Pharmacol Rev       Date:  2021-10       Impact factor: 18.923

Review 6.  Are Type 1 metabotropic glutamate receptors a viable therapeutic target for the treatment of cerebellar ataxia?

Authors:  Emmet M Power; Natalya A English; Ruth M Empson
Journal:  J Physiol       Date:  2016-02-24       Impact factor: 5.182

Review 7.  A GluD Coming-Of-Age Story.

Authors:  Michisuke Yuzaki; A Radu Aricescu
Journal:  Trends Neurosci       Date:  2017-01-19       Impact factor: 13.837

8.  Altered Actions of Memantine and NMDA-Induced Currents in a New Grid2-Deleted Mouse Line.

Authors:  Ayako Kumagai; Akira Fujita; Tomoki Yokoyama; Yuki Nonobe; Yasuhiro Hasaba; Tsutomu Sasaki; Yumi Itoh; Minako Koura; Osamu Suzuki; Shigeki Adachi; Haruko Ryo; Arihiro Kohara; Lokesh P Tripathi; Masato Sanosaka; Toshiki Fukushima; Hiroyuki Takahashi; Kazuo Kitagawa; Yasuo Nagaoka; Hidehisa Kawahara; Kenji Mizuguchi; Taisei Nomura; Junichiro Matsuda; Toshihide Tabata; Hiroshi Takemori
Journal:  Genes (Basel)       Date:  2014-12-11       Impact factor: 4.096

Review 9.  Systematic review of autosomal recessive ataxias and proposal for a classification.

Authors:  Marie Beaudin; Christopher J Klein; Guy A Rouleau; Nicolas Dupré
Journal:  Cerebellum Ataxias       Date:  2017-02-23

10.  Homozygous GRID2 missense mutation predicts a shift in the D-serine binding domain of GluD2 in a case with generalized brain atrophy and unusual clinical features.

Authors:  Zafar Ali; Shumaila Zulfiqar; Joakim Klar; Johan Wikström; Farid Ullah; Ayaz Khan; Uzma Abdullah; Shahid Baig; Niklas Dahl
Journal:  BMC Med Genet       Date:  2017-12-06       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.